President Trump criticized the exorbitant prices of diabetes drugs like Ozempic in the U.S., which costs $1,200 compared to just $88 in London. During an interview, he linked this price disparity to broader issues of trade and drug pricing, alleging that the U.S. is too lenient. He emphasized that similar medications are manufactured identically yet sold at vastly different prices. Trump attributed these issues to a lack of transparency measures, which he claimed were revoked by Biden, and proposed that governors purchase medications in bulk from Canada to reduce costs for Americans.
In London, you get it for $88. In New York, you get it for $1,200. The identical package made in the same factory, shipped to different places, but made literally in the same factory.
Everything's added onto the United States because the United States has been too nice. You know, I had transparency done, and Biden canceled it. Transparency would have solved that problem.
Collection
[
|
...
]